Navitas Semiconductor Stock Soared: Why It Jumped Today
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
What Is Glide Path In Target Date Funds
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articles
Trump Memorandum of Understanding with Iran Sparks Markets
Trump appears set to scrap the memorandum of understanding with Iran, yet U.S. markets are largely muted as traders f...
Tandem Diabetes Care Stock Surges on Profitability Gains
A sharp rally in tandem diabetes care stock followed a profitability upgrade, signaling a shift from revenue-only gro...
Gold Miners with Different Edges: Two Paths to Gold
Gold prices lure investors to miners as a way to gain leveraged exposure to gold. This article compares two different...
ChatGPT Claude Models Split on XRP Hitting $3 by Q4
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
MiB: Jean Eric Salata — Investing Leader’s Global View
A deep dive into mib: jean eric salata, chair of EQT, exploring how cross-cultural experience and AI-driven infrastru...
Nano Nuclear Energy Millionaire: Tiny Reactors, Big Wealth
Could a little technology change your big financial future? This deep dive explains how nano nuclear energy and small...
Axsome (AXSM) 2025 Earnings: Axsome (axsm) 2025 Earnings
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
Nebius Stock Fell Today: Debt Plans and AI Deals Explained
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
How Much Higher Mortgage Rates Could Go in 2026 for Homebuyers
As the 10-year yield fluctuates and inflation data shape policy bets, homeowners and buyers ask how much higher mortg...
From $50K to $10M: The Leveraged ETF Bet Pays Off
A retail trader’s bold bet on a 3x leveraged Nasdaq ETF turned a modest starting sum into a multimillion-dollar run b...
Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status